XAGRID®

· Shire

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XAGRID®, covering 2014-07-29 to 2023-02-20. Get the full timeline:

Most recent: EMA Authorised: Xagrid (anagrelide) — Takeda Pharmaceuticals International AG Ireland